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A B S T R A C T
Though investigations into the use of massively parallel sequencing technologies for the generation of
complete mitochondrial genome (mtGenome) proﬁles from difﬁcult forensic specimens are well
underway in multiple laboratories, the high quality population reference data necessary to support full
mtGenome typing in the forensic context are lacking. To address this deﬁciency, we have developed 588
complete mtGenome haplotypes, spanning three U.S. population groups (African American, Caucasian
and Hispanic) from anonymized, randomly-sampled specimens. Data production utilized an 8-amplicon,
135 sequencing reaction Sanger-based protocol, performed in semi-automated fashion on robotic
instrumentation. Data review followed an intensive multi-step strategy that included a minimum of
three independent reviews of the raw data at two laboratories; repeat screenings of all insertions,
deletions, heteroplasmies, transversions and any additional private mutations; and a check for
phylogenetic feasibility. For all three populations, nearly complete resolution of the haplotypes was
achieved with full mtGenome sequences: 90.3–98.8% of haplotypes were unique per population, an
improvement of 7.7–29.2% over control region sequencing alone, and zero haplotypes overlapped
between populations. Inferred maternal biogeographic ancestry frequencies for each population and
heteroplasmy rates in the control region were generally consistent with published datasets. In the coding
region, nearly 90% of individuals exhibited length heteroplasmy in the 12418-12425 adenine
homopolymer; and despite a relatively high rate of point heteroplasmy (23.8% of individuals across
the entire molecule), coding region point heteroplasmies shared by more than one individual were
notably absent, and transversion-type heteroplasmies were extremely rare. The ratio of nonsynonymous
to synonymous changes among point heteroplasmies in the protein-coding genes (1:1.3) and average
pathogenicity scores in comparison to data reported for complete substitutions in previous studies seem
to provide some additional support for the role of purifying selection in the evolution of the human
mtGenome. Overall, these thoroughly vetted full mtGenome population reference data can serve as a
standard against which the quality and features of future mtGenome datasets (especially those
developed via massively parallel sequencing) may be evaluated, and will provide a solid foundation for
the generation of complete mtGenome haplotype frequency estimates for forensic applications.
 2014 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-
ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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Massively parallel sequencing (MPS) technologies hold great
potential for efforts to expand forensic mitochondrial DNA
(mtDNA) typing beyond current capabilities. Since the ﬁrst such
technology was introduced in 2005 [1], MPS has transformed
genetic data generation in many ﬁelds of research, including
ancient DNA (for an overview of some ancient DNA studies that
have used MPS, see Table 1 in Knapp and Hofreiter [2]; and for a
review of the application of MPS to mtDNA sequencing in
particular, see Ho and Gilbert [3] and Paijmans et al. [4]). The
advantages of MPS in comparison to traditional Sanger-type
sequencing that have been exploited for analyses of ancient
samples also have clear relevance to the low DNA quantity and/or
quality specimens to which mtDNA typing is often applied in
forensics, where typically only the control region (CR) or portions
thereof are targeted due to both limited sample quantities and the
enormous cost and effort required to generate Sanger-based
proﬁles to forensic standards. Recent studies have demonstrated
both that (1) MPS can effectively recover complete mitochondrial
genome (mtGenome) proﬁles even from highly damaged and
degraded forensic samples [5,6], and (2) that full mtGenome
sequencing by MPS may be cost-effective in comparison to
methods currently used by the forensic community for mtDNA
data generation [7]. While much further work remains before MPS-
based protocols (whether for mtGenome or nuclear genome
typing) can be fully validated for forensic use and routinely applied
to forensic casework specimens, the ongoing research into MPS for
forensic application in many laboratories [5–19] clearly indicates
the direction in which the ﬁeld is moving.
At present, though, one of the barriers to wider implementation
of complete mtGenome typing in forensic casework is the lack of
appropriate reference databases [6,20]. In forensics, weight is
assigned to the results of an mtDNA match comparison by
estimating the frequency of the mtDNA haplotype given a relevant
population sample. While concerted efforts have been put forth in
recent years to establish high-quality mtDNA control region
reference datasets representing U.S. and global population groups
[21–23], similar initiatives targeting the mtDNA coding region
have been lacking. Although more than 20,000 complete human
mtGenome sequences have now been published (see the PhyloTree
website http://www.phylotree.org/mtDNA_seqs.htm [24] for a
comprehensive list of publications as of 19 February 2014), none
have been developed as U.S.-wide population reference data that
meet current forensic standards [20,25,26].
To meet the need for forensic-quality population reference data
for the full mtGenome, we report here 588 mtGenome haplotypes
from three U.S. populations (African American, U.S. Caucasian and
U.S. Hispanic). These Sanger-based data were developed in
accordance with current best practices for mtDNA data generation
[25,26] to ensure their suitability for forensic use. In this paper we
report summary statistics for the complete mtGenome and evaluate
the statistical weight of a previously unobserved haplotype, and we
compare the composition of each population sample to previously
published CR-based datasets to establish their consistency and
representativeness. In addition, we examine the coding region
insertion/deletion polymorphisms (indels) and the heteroplasmies
detected in the haplotypes in detail to help inform future analyses
and use of complete mtGenome data for forensic and other purposes.
2. Materials and methods
2.1. Specimens and sampling
The samples used for this databasing initiative were anon-
ymized blood serum specimens from the Department of DefenseSerum Repository (DoDSR; [27]). The 175 African-American, 275
U.S. Caucasian, and 175 U.S. Hispanic samples initially targeted for
processing were selected randomly from specimens in the DoDSR
collection. Specimens were received with only state and self-
reported population/ethnicity information.
This research involving human subjects, human material or
human data was reviewed by the U.S. Army Medical Research and
Materiel Command’s Ofﬁce of Research Protections, Institutional
Review Board Ofﬁce, and was granted an exemption from requiring
ethics approval.
2.2. mtGenome data generation
Full mtGenome haplotypes were generated from the blood
serum specimens using the protocol and high-throughput
processing strategy described in Lyons et al. [28], with the minor
modiﬁcations described in Just et al. [29]. In brief:
Blood serum specimens were robotically transferred from tubes
to 96-well plates. Genomic DNA was extracted from 100 ml of
blood serum using the QIAamp 96 DNA Blood Kit (QIAGEN,
Valencia, CA), and a combination of robotic pipetting and manual
centrifugation. DNA was eluted from the silica columns using
either 100 ml or 200 ml of TE buffer (10 mM Tris and 0.5 mM
EDTA), and the eluate was evaporated to eliminate any potential
ethanol carryover. DNA extracts were resuspended in 100 ml of
either UV-irradiated deionized water or TE buffer. Some, but not
all, DNA extracts were quantiﬁed prior to PCR, using an mtDNA
quantitative PCR (qPCR) assay [30] adapted from Niedersta¨tter
et al. [31].
Ampliﬁcation of the complete mtGenome was performed in
eight overlapping fragments on robotic instrumentation, using the
primers and conditions detailed in Lyons et al. [28] and Just et al.
[29]. When qPCR results indicated DNA quantities less than 10 pg/
ml, extract input for PCR was doubled from 3 ml to 6 ml. In some
cases, such as when specimens from the same extract plate had
previously exhibited evidence of inhibition, or to improve ﬁrst-
pass processing success for one or two of the eight mtGenome
region targets with the poorest ampliﬁcation efﬁciency among the
lowest DNA quantity specimens, polymerase (AmpliTaq Gold, Life
Technologies, Applied Biosystems, Foster City, CA) inputs were
doubled from 2.5 to 5 units.
Ampliﬁcation success was evaluated via capillary electropho-
resis using automated injection directly from the 96-well PCR
plate. When only one of the eight target fragments failed to amplify
for a sample, the failed PCR was repeated manually, and the
successful PCR product was manually transferred to the original
96-well PCR plate for further processing. When two or more PCR
failures for a single sample were encountered, typically no further
attempts at ampliﬁcation were made, and the sample was not
carried through to sequencing. PCR product puriﬁcation of
successfully ampliﬁed extracts was performed enzymatically in
the 96-well PCR plates.
Sanger sequencing was performed in 96-well plate format on
robotic instrumentation using the 135 primers and conditions
described in Lyons et al. [28]. Sequencing products were puriﬁed
via gel ﬁltration columns using a combination of automated
pipetting and manual centrifugation. Puriﬁed sequencing
products were evaporated, resuspended in formamide, and
detected on an Applied Biosystems 3730 DNA Analyzer
(Life Technologies, Applied Biosystems) using a 50 cm capillary
array.
All sample transfer steps (and nearly all liquid-handling steps)
for all stages of the automated sample processing were performed
robotically. For any manual re-processing, at least one, and
sometimes two, witnesses were used for all sample/PCR product
pipetting steps during reaction set-ups and transfers.
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The data review workﬂow employed for this project is
described in brief in Just et al. [29], and is a version of the review
strategy described by Irwin et al. [22] modiﬁed for complete
mtGenome data developed using a multi-amplicon strategy. The
workﬂow is in accordance with the current Scientiﬁc Working
Group on DNA Analysis Methods (SWGDAM) and International
Society for Forensic Genetics (ISFG) best practice guidelines for
forensic mtDNA data development [25,26]. Data review was
performed by at least three distinct scientists at two different
laboratories: the Armed Forces DNA Identiﬁcation Laboratory
(AFDIL); and the Institute of Legal Medicine, Innsbruck Medical
University (GMI), curator of the European DNA Proﬁling Group
mtDNA population (EMPOP) database (www.empop.org) [23]. In
detail, the review steps were as follows.
2.3.1. AFDIL primary analysis
Initial assembly, trimming and review of the raw sequence data
for each sample was performed in Sequencher version 4.8 or 5.0
(Gene Codes Corporation, Ann Arbor, MI). Sequences were aligned
to the revised Cambridge Reference Sequence (rCRS; [32,33])
following phylogenetic alignment rules [25,26,34].
In cases of length heteroplasmy (LHP), a single dominant
variant was identiﬁed (as per recommendations for mtDNA data
interpretation [26,34]). With regard to point heteroplasmy (PHP),
an mtGenome position was deemed heteroplasmic only if speciﬁc
criteria were met upon visual review of the raw sequence data:
(1) If the minor sequence variant was readily visible (i.e., a distinct
peak of normal morphology with white space beneath it could
be seen in the trace data without changing the chromatogram
view in Sequencher to examine the signal closer to the
baseline) in all of the sequences covering the position, and
those sequences were generated using both forward and
reverse primers, a PHP was called.
(2) If the minor sequence variant was readily visible in some but
not all sequences, data closer to the baseline were inspected for
each sequence. If the baseline view demonstrated that the
minor variant was substantially higher than any sequence
background/noise in (a) the majority of the sequences, and (b)
both forward and reverse sequences, a PHP was called.
When heteroplasmy was suspected but not conﬁrmed accord-
ing to the above criteria, additional sequence data were generated
for the sample/region to clarify the presence or absence of
heteroplasmy.
Once each sample haplotype was complete (i.e., every
mtGenome position had at least two strands of high-resolution
sequence coverage), a list of differences from the rCRS was
prepared manually, and a variance report was electronically
exported from Sequencher.
2.3.2. AFDIL secondary analysis
Each mtGenome haplotype contig generated during the primary
analysis of the raw data was reviewed on a position-by-position
basis by a second scientist. A list of differences from the rCRS was
generated manually and compared to the list generated at the
primary analysis stage, and any discrepancies were resolved to the
satisfaction of both reviewers. A variance report was again exported
from Sequencher, and compared to the manually-prepared lists of
differences from the rCRS to ensure full agreement across all paper
and electronic records. In addition, sequences present in the ﬁnal
sample contig were visually examined to conﬁrm that all sequences
had the same sample identiﬁer (i.e., that no sequences from a
different sample were mistakenly included).2.3.3. AFDIL database entry and initial review
The Sequencher variance reports exported at the secondary
analysis stage were electronically imported into the custom
software Laboratory Information Systems Applications (LISA;
Future Technologies Inc., Fairfax VA). For each sample, the
imported record was compared to the handwritten list of
differences from the rCRS prepared in the previous data analysis
stage to conﬁrm that the database record was consistent with the
paper record. In addition, all coding region indels, PHPs and
transversions in each electronic proﬁle were visually conﬁrmed by
re-review of the raw data at the relevant positions.
2.3.4. AFDIL database ﬁnal review
To conﬁrm the database haplotypes, a second scientist again
reviewed each electronic record in comparison to the previously-
generated lists of differences from the rCRS, and checked that the
correct sequence coverage range (1-16,569 base pairs) was
associated with each proﬁle.
2.3.5. Phylogenetic check
As described in Just et al. [29], given the multi-amplicon PCR
protocol used for data generation in this project, each mtGenome
haplotype was evaluated for phylogenetic feasibility as a quality
control measure. Haplotypes were ﬁrst assigned a preliminary
haplogroup, and subsequently compared to the then-current
version of PhyloTree (Build 14 or 15, depending on the dates on
which different subsets of the data were checked) [24] to assess
each difference from the rCRS. The raw data for each sample were
re-reviewed to conﬁrm (a) any expected mutations (based on the
preliminary haplogroup) that were lacking, (b) all private
mutations (mutations not part of the haplogroup deﬁnition),
and (c) all PHPs and transversions.
2.3.6. EMPOP review
Sequencher project ﬁles, variance reports and all raw data for
each sample were electronically transferred to EMPOP for tertiary
review. At EMPOP, each mtGenome haplotype contig was again
reviewed on a position-by-position basis, and edits to the project
ﬁles were made as warranted. A variance report of differences from
the rCRS was exported from Sequencher and imported into a local
database.
2.3.7. Concordance check
EMPOP and AFDIL-generated variance reports for each haplo-
type were electronically compared in the local database at EMPOP.
Any discrepancies between the haplotypes were reported to
AFDIL; and for those samples with discrepancies, the raw data
were re-examined by both laboratories for the positions in
question. In a few cases, sample re-processing was performed at
this stage to clarify the haplotypes. The sample haplotypes were
considered ﬁnalized once both EMPOP and AFDIL were in
agreement, and all relevant ﬁles had been corrected at AFDIL
and re-sent to EMPOP.
2.3.8. Haplogroup assignment
Haplogroups were assigned to each mtGenome haplotype using
EMMA [35] and Build 16 of PhyloTree [24]. These automated
assignments were then compared to the preliminary haplogroups
assigned at the phylogenetic check stage, and any discrepancies
were evaluated in detail. In all cases, the EMMA-estimated
haplogroup was the ﬁnal haplogroup assigned to the sample.
2.3.9. Indel screening
All indels relative to the rCRS in the completed haplotypes were
reviewed to assess correct placement according to phylogenetic
alignment rules [25,26,34] and PhyloTree Build 16 [24].
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All point heteroplasmies in the ﬁnal haplotypes were compared
to a list of positions at which two speciﬁc NUMTs (on Chromo-
somes 1 and 5, and possessing greater than 90% similarity to
modern human mtDNA; see Table 3 in Lyons et al. [28]) differ from
the rCRS. Any haplotypes with point heteroplasmies that occurred
at one of these positions were re-reviewed by careful examination
of the raw data to ensure that the point heteroplasmy was not due
to co-detection of a NUMT (which would be expected to present as
multiple mixed positions within the amplicon in question [28]).
2.3.11. Data transfer and corrections
All data transfer steps into internal databases and between
laboratories were performed electronically. When changes were
made to haplotypes at AFDIL after the initial transfer of sample ﬁles
to EMPOP, all relevant sample ﬁles were re-sent to EMPOP for
complete replacement (i.e., no manual changes were made to
haplotypes at EMPOP).
2.4. Data analyses
Summary statistics (number of haplotypes, number of unique
haplotypes, random match probability, haplotype diversity and
power of discrimination) for multiple regions of the mtGenome
(hypervariable region 1 (HV1) only; HV1 and hypervariable region
2 (HV2) in combination; the complete CR; and the full mtGenome)
were based on pairwise comparisons of each of the three
populations in the LISA custom software. Cytosine insertions at
nucleotide positions 309, 573 and 16193 were ignored for the
analyses, and point heteroplasmies were treated as differences.
Estimations of broad scale maternal biogeographic ancestry
(African, East Asian, West Eurasian or Native American) were based
on the haplogroups assigned to each haplotype. For the few
haplogroup M, N and U lineages which have overlapping present
day distributions in certain geographic regions (North Africa,
southern Europe and the Near East), assignment to one of the
ancestry categories was made on the basis of the geographic
distribution of the same or closely related lineages in global
populations represented in a beta version of the EMPOP3 database
[36].
Pairwise comparisons of the haplotypes representing each
population and biogeographic ancestry group were performed for
(a) the full mtGenome, and (b) with comparisons restricted to the
CR, in the LISA custom software. Cytosine insertions at nucleotide
positions 309, 573 and 16193 were ignored for the analyses.
Statistical calculations to assess signiﬁcance were performed
either in Microsoft Ofﬁce Excel 2010, or, for Chi-Square tests of
independence (for comparisons of differing proportions), using the
calculator spreadsheet available for download from http://
udel.edu/mcdonald/statchiind.html [37].
Likelihood ratios (LRs) were developed using two methods: the
‘‘exact’’ method for conﬁdence intervals (Clopper–Pearson) [38]
and the ‘‘kappa method’’ [39]. Clopper–Pearson 95% conﬁdence
intervals were calculated using HaploCALc Version 1.8 by Steven
Myers (steven.myers@doj.ca.gov). LR calculations using the one-
tailed conﬁdence interval used the standard formula LR = x/y,
where x represents the probability that the questioned and known
haplotypes represent the same maternal lineage, and y is the
probability that the questioned sample will match an unrelated (or
only randomly related) haplotype in the database. The value used
for x was always 1, and the value used for y was the one-tailed 95%
conﬁdence limit. LR calculations for the kappa method used Eq. (6)
from Brenner [39]: LRk = n/(1  k), where k represents the
proportion of haplotypes in the population sample that are
singletons (haplotypes observed only once), and n represents the
size of the population sample.3. Results and discussion
3.1. Data generation and review
A variety of data processing metrics were previously detailed
for a subset of the low template blood serum samples used for this
study [29].
As described in Section 2.2, samples that exhibited a single PCR
failure during the initial, automated processing were manually
reampliﬁed to obtain PCR product that could be carried through to
sequencing, whereas samples for which more than one of the eight
target mtGenome regions failed to amplify were typically
abandoned and not processed beyond ampliﬁcation. Out of a total
of 625 samples that were attempted, 37 were dropped due to PCR
failure in two or more of the eight mtGenome target regions. As we
previously reported, among the ﬁrst 242 quantiﬁed samples
processed, all 12 samples dropped due to multiple PCR failures had
PCR DNA input quantities less than 10 pg/ml [29]. But, as PCR
failures can occur due to primer binding site mutations, and those
mutations may be haplogroup or lineage-speciﬁc, we explored the
extent of PCR failure across all 588 completed haplotypes in
relation to the PCR strategy employed.
An examination of the incidence and pattern of PCR failure
among samples with primer binding region mutations indicates
that such mutations are unlikely to have biased the ﬁnal datasets
for any of the three population samples. A total of 52
polymorphisms, representing 34 distinct mutations, were found
across the 16 primer binding regions. Primer binding region
mutations were found in 46 of the 588 completed samples (7.8%),
and overall had the potential to impact primer binding in 1.1% of
the initial eight high-throughput PCR reactions performed per
sample (a total of 4704 PCR reactions). Yet, manual reampliﬁcation
(due to near or complete PCR failure) was required in only eight of
the 52 instances in which a mutation was later found in a PCR
primer binding region; and thus primer binding region polymor-
phisms potentially caused PCR failure in just 1.4% of samples and
0.2% of ampliﬁcations. Further, as Fig. S1 demonstrates, the
position of the mutation relative to the 30 end of the primer was
highly variable in these eight instances of reampliﬁcation, and thus
the mutation may not have been the reason for the PCR failure in all
eight cases. Among the 46 samples which were carried through to
sequencing and later found to have polymorphisms in primer
binding regions, ﬁve (8.9%) exhibited a mutation in more than one
of the 16 primer binding regions, yet only three PCR failures (of 10
potentially affected reactions) were observed among these ﬁve
samples.
Given the wide variety of mtDNA haplogroups represented by
the 588 haplotypes reported in this study (see Section 3.2), and the
low DNA quantities for the ﬁrst twelve samples abandoned [29],
the very low overall incidence of reampliﬁcation among samples
with known primer binding region mutations suggests that (1) PCR
failure due to haplogroup-speciﬁc polymorphism when using the
Lyons et al. [28] primers is likely to be quite infrequent, and (2) few,
if any, of the abandoned samples exhibited multiple PCR failures
due to primer binding region mutations. It is therefore unlikely
that the PCR or sample handling strategy introduced any particular
bias into the datasets reported here.
The formalized data review process employed for this study
(see Section 2.3) included an electronic comparison of the
haplotypes independently developed by AFDIL and EMPOP from
the raw sequence data. Across the 588 haplotypes compared, 27
discrepancies in 23 samples were identiﬁed, a non-concordance
rate of 4.6%. The majority of these discrepancies (70%) were due
to missed or incorrectly identiﬁed heteroplasmies in either the
AFDIL or EMPOP analysis; and for three of these samples manual
reprocessing (reampliﬁcation and repeat sequencing) was
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low-level point heteroplasmy was or was not present. The
remaining discrepancies were due either to raw data editing
differences (two instances) or indel misalignments (six
instances).
In addition to the differences found upon cross-check of the
haplotypes, two further indel misalignments were later identiﬁed
during additional review of the datasets. In both instances the
original alignment of the sequence data was inconsistent with
phylogenetic alignment rules and the current mtDNA phylogeny
[24–26,34]. In one case, a haplotype with 2885 2887del 2888del
was incorrectly aligned as 2885del 2886del 2887; and in the
second case, a haplotype with 292.1A 292.2T was incorrectly
aligned as 291.1T 291.2A. For these two haplotypes the indels were
misaligned by both AFDIL and EMPOP, and thus no discrepancy
was identiﬁed as part of the concordance check. The identiﬁcation
of these two misalignments prompted a thorough review of all
2767 indels present in the 588 haplotypes, and no additional
misalignments were found.
Fig. S2 provides a breakdown of the 29 total data review issues
identiﬁed in this study. The results of the concordance check and
the two additional indel misalignments identiﬁed later both (1)
underscore the need for multiple reviews of mtDNA sequence data
to ensure correct haplotypes are reported, and (2) highlight a need
for an automated method for checking regions of the mtGenome
prone to indels prior to dataset publication and inclusion in a
database. EMPOP includes a software tool that evaluates CR indel
placement and is routinely employed to examine CR datasets prior
to their inclusion in the database. Until a similar tool is developed
to reliably assess complete mtGenome haplotypes, all indels in
complete mtGenome datasets should be reviewed in relation to the
current knowledge regarding the human mtDNA phylogeny prior
to publication.
3.2. Database composition and statistics
In total, 588 complete mtGenome haplotypes were generated
from three U.S. populations: African American (n = 170), U.S.
Caucasian (n = 263) and U.S. Hispanic (n = 155). The number of
samples per U.S. state/territory for each population is given in
Table S1.Table 1
Summary statistics. Summary statistics were calculated for each of the three U.S. populat
HV2 in combination, the entire CR, and the full mtGenome. Haplotype diversity was calcu
number of distinct haplotypes and the number of haplotypes unique in each population
portion of the molecule.
HV1 HV1/HV2 CR 
African American (n = 170)
# Haplotypes 124 140 148 
# Unique haplotypes 106 120 130 
Random match probability 1.38% 0.92% 0.78% 
Haplotype diversity 0.9920 0.9967 0.9981 
Power of discrimination 99.20% 99.67% 99.81% 
U.S. Caucasian (n = 263)
# Haplotypes 151 200 229 
# Unique haplotypes 122 170 211 
Random match probability 2.75% 0.96% 0.60% 
Haplotype diversity 0.9762 0.9942 0.9978 
Power of discrimination 97.62% 99.42% 99.78% 
U.S. Hispanic (n = 155)
# Haplotypes 119 134 141 
# Unique haplotypes 102 121 130 
Random match probability 1.27% 0.90% 0.79% 
Haplotype diversity 0.9937 0.9974 0.9986 
Power of discrimination 99.37% 99.74% 99.86% The 580 distinct mtGenome haplotypes that were observed are
presented in Tables S2–S4, and are available in GenBank (accession
numbers KM101569–KM102156). Summary statistics for each
population are given in Table 1. Across the entire mtGenome, 168
of 170 (98.8%) African American haplotypes, 255 of 263 (97.0%) U.S.
Caucasian haplotypes, and 140 of 155 (90.3%) U.S. Hispanic
haplotypes were unique in the respective datasets when cytosine
insertions at positions 309, 573 and 16193 were ignored. With
regard to the summary statistics, the additional value added by
sequencing the complete mtGenome is most powerfully demon-
strated by comparing the information gleaned from the subsets of
the molecule historically targeted for forensic typing. For example,
for the African American population sample, the increase in the
number of unique haplotypes that would be detected by HV1 and
HV2 sequencing compared to HV1 sequencing alone is 13.2%; and
moving from HV1 and HV2 typing to complete CR sequencing
would increase the number of unique haplotypes detected by 8.3%.
In comparison to CR sequencing, complete mtGenome sequencing
would increase the number of singletons by 29.2% for this
population sample – well more than double the increase seen
by moving either from HV1 alone to HV1/HV2, or from HV1/HV2 to
the full CR. These improvements in lineage resolution are
consistent with a recent examination of 283 mtGenome haplo-
types from three Texas population samples [7]; however, the
random match probabilities reported here are lower due to the
larger sample sizes in our study.
Given the substantially higher degree of haplotype resolution
with full mtGenome sequences in comparison to smaller portions
of the molecule, we investigated the LRs that would be calculated
for previously unobserved haplotypes when considering HV1/HV2
alone, the CR and the complete mtGenome using two different
methods: Clopper–Pearson [38] and the ‘‘kappa method’’ pub-
lished by Brenner [39]. Conﬁdence interval calculations with the
Clopper–Pearson ‘‘exact’’ method use the cumulative probability
from a binomial distribution given the number of observations of
interest and a sample size; and thus for previously unobserved
haplotypes in a database, Clopper–Pearson 95% conﬁdence
intervals (either one-tailed or two-tailed) and the resulting LRs
will depend entirely on the size of the reference population sample.
By contrast, as Brenner’s kappa method uses the proportion of
singletons (haplotypes observed only once) in a population sampleions for several regions historically targeted for forensic typing: HV1 alone, HV1 and
lated as (1  Random Match Probability)  ((n  1)/n). The percentage increase in the
 (observed for only a single individual) were calculated for each successively larger
mtG Percentage increase
HV1 to HV1/HV2 HV1/HV2 to CR CR to mtG
169 12.9% 5.7% 14.2%
168 13.2% 8.3% 29.2%
0.60%
0.9999
99.99%
259 32.5% 14.5% 13.1%
255 39.3% 24.1% 20.9%
0.39%
0.9999
99.99%
147 12.6% 5.2% 4.3%
140 18.6% 7.4% 7.7%
0.72%
0.9992
99.92%
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a previously unobserved mtDNA haplotype will depend both on
database size and the portion of the molecule targeted (as Table 1
demonstrates that the proportion of singletons will be greater as
the size of the targeted mtDNA region increases).
In comparison to the Clopper–Pearson one-tailed method
(currently recommended for use in U.S. laboratories [25]), LRs
developed using the kappa method ranged from 8- to 14-fold
higher across our three population samples when only HV1 and
HV2 were considered, and from 13- to 18-fold higher when the full
CR was considered (Table 2). When the numbers of singletons
across the entire mtGenome were used, LRs developed by the
kappa method were 31- to 254-fold higher in comparison to the
Clopper–Pearson method using a 1-tailed 95% upper conﬁdence
limit. Similar values were obtained for the full mtGenome
haplotypes recently published by King et al. [7]. While the most
conservative haplotype frequency estimate may be preferred for
some purposes, it is clear from these results that LR calculations
using the Clopper–Pearson method negate some of the beneﬁts of
the increased resolution achieved by typing the complete
mtGenome. Until larger full mtGenome databases are available,
Clopper–Pearson based LRs developed for previously unobserved
mtGenome haplotypes will be reduced in comparison to even
shared haplotypes based on smaller subsets of the molecule given
the size of current CR databases (for example, 2823 African
American CR haplotypes are presently available in EMPOP, Release
11 [23]). That is, despite the clearly smaller likelihood of
encountering a matching mtGenome haplotype versus a matching
CR haplotype (for example) among randomly-selected individuals
(Table 1), Clopper–Pearson LRs for full mtGenome haplotypes will,
for the time being, be smaller due to database size alone.
On the basis of the EMMA [35] analyses and comparisons to
Build 16 of PhyloTree [24], 393 distinct named haplogroups were
assigned to the 588 haplotypes reported in this study (Tables S2–
S4). Across the three population samples, all major haplogroups
were represented except L4, L5, L6, O, P, Q, S and Z. The frequency of
each major haplogroup by population is given in Table 3, and Table
S5 details the speciﬁc haplogroups present in each population at
greater than 5.0%. The level of phylogenetic resolution of the
haplogroups in the latter table was selected to ease more direct
comparison to previous, CR-based mtDNA studies; however more
highly resolved haplogroup categorizations are included where the
frequencies also exceed 5%. These data provide a snapshot of the
predominant lineages found in each of the population samples.
Based on the assigned haplogroups, the 588 mtGenome
haplotypes were classiﬁed into one of four broad biogeographic
ancestry categories: African, East Asian, West Eurasian and
Native American (Fig. 1). As has been previously reported [40],Table 2
Likelihood ratios for unobserved haplotypes using two different methods. Clopper–Pear
calculate LRs for a haplotype not present in the database, for (a) both the three populatio
et al. [7], and (b) given different portions of the mtGenome. As deﬁned by Brenner [39
number of singletons in the King et al. [7] datasets were obtained from their Table 1 (
Clopper–Pearson [38] 
1-tailed 2-tailed HV1/HV2 
95% CI LR Upper 95% CI LR Singletons 
This study
African American (n = 170) 0.0175 57 0.0215 47 120 
U.S. Caucasian (n = 263) 0.0113 88 0.0139 72 170 
U.S. Hispanic (n = 155) 0.0191 52 0.0235 43 121 
King et al. [7]
Texas African American (n = 87) 0.0338 30 0.0415 24 76 
Texas Caucasian (n = 83) 0.0354 28 0.0435 23 77 
Texas Hispanic (n = 113) 0.0262 38 0.0321 31 96 
a As modeled in Brenner [39] to avoid k = 1.self-identiﬁed ancestry was highly correlated with maternal
biogeographic ancestry for the African American and U.S. Caucasian
populations. For the African American dataset, the vast majority of
haplotypes (90.0%) were assigned to haplogroups L0, L1, L2 and L3;
whereas only 2.4%, 4.7% and 2.9% of the haplotypes represent East
Asian, West Eurasian and Native American ancestry, respectively.
Similarly, 94.7% of the U.S. Caucasian haplotypes in this population
sample are of West Eurasian ancestry, with only minor contributions
from African, East Asian and Native American lineages (0.8%, 1.9%
and 2.7%, respectively). By contrast, while the majority (60.0%) of the
U.S. Hispanic population sample was comprised of Native American
lineages, West Eurasian and African maternal ancestries were
represented in substantial proportions (25.8% and 12.3% of
haplotypes, respectively).
Comparisons between the population samples reported here
and previously published CR-based datasets were made on the
basis of biogeographic ancestry proportions, as these can
typically be ascertained for most haplotypes given CR data
alone. Table 4 provides the ancestry percentages for the current
study as well as for two previous studies for each of the three U.S.
population groups [40–45]. For the African American and U.S.
Caucasian populations, the proportion of haplotypes reﬂecting
the predominant ancestry is not statistically signiﬁcantly
different between this and previous studies. However, for the
U.S. Hispanic population, the differing proportions of Native
American haplotypes across three population samples (this
study, [44] and [42]) are signiﬁcant (p = 0.007). Speciﬁcally,
the proportion of Native American haplotypes in the U.S.
Hispanic population sample reported here differs signiﬁcantly
from that reported in the Allard et al. [42] study (p = 0.008), even
after Bonferroni correction for multiple tests. This is most likely
due to differences in geographic sampling, which will reﬂect the
substantial regional differences in the Native American compo-
nent of a U.S. Hispanic population sample [22]. Along these lines,
the proportion of haplotypes representing Native American
maternal ancestry in a recently published Southwest Hispanic
population sample from Texas (71.7%; [7]) is highly similar to the
frequency of Native American haplotypes (70.8%) in the Allard
et al. study [42].
In addition to comparisons based on inferred maternal
biogeographic ancestry, we also compared the haplotype distribu-
tion for the African American population sample reported in this
study to that described by Salas et al. [46] in their analysis of an FBI
dataset [47]. When using the same haplogroup categories and level
of phylogenetic resolution, the composition of our African
American sample (Fig. S3) is nearly identical to Fig. 1 in Salas
et al. [46], and reﬂects the predominantly West African, west-
central African and southwestern African origins of the mtDNAson 95% conﬁdence intervals [38] and Brenner’s ‘‘kappa method’’ [39] were used to
n samples reported in this study and the three population samples reported by King
], k refers to the proportion of singletons (unique haplotypes) in the database. The
no full CR values were reported).
Brenner kappa [39]
CR Full mtGenome
k LRk Singletons k LRk Singletons k LRk
0.7059 578 130 0.7647 723 168 0.9882 14,450
0.6464 744 211 0.8023 1330 255 0.9696 8646
0.7806 707 130 0.8387 961 140 0.9032 1602
0.8736 688 85 0.9770 3785
0.9277 1148 83 >0.99a 9222
0.8496 751 111 0.9823 6384
Table 3
Haplogroup frequencies by population. Frequencies for each major haplogroup for
each population are given in bold. Where more than one of four the biogeographic
ancestries (African [AF], East Asian [EA], West Eurasian [WE], and Native American
[NA]) are represented in the haplotypes assigned to each major haplogroup,
subhaplogroup percentages (italicized) are also included. When more than one
ancestry group could have been assigned due to overlapping geographic
distributions, the ancestry group that was assigned is underlined. Percentage
totals for each population group may not appear to equal 100.0% due to decimal
place rounding for each haplogroup.
Haplogroup African American U.S. Caucasian U.S. Hispanic
A 1.8% 1.1% 26.5%
A2 (NA) 1.2% 0.8% 26.5%
A5, A10 (EA) 0.6% 0.4%
B 0.6% 1.5% 16.1%
B2 (NA) 0.6% 1.1% 15.5%
B4 (EA) 0.4% 0.6%
C 0.6% 0.8% 12.3%
C1b, C1c, C4c (NA) 0.6% 0.8% 12.3%
D 0.6% 5.8%
D1, D4h3 (NA) 5.8%
D4e (EA) 0.6%
E 0.6%
F 0.6% 0.4%
G 0.4%
H 1.8% 36.5% 11.6%
HV 2.3%
I 2.3% 1.3%
J 13.7% 1.3%
K 1.2% 8.0% 3.9%
L0 2.9% 0.6%
L1 17.1% 2.6%
L2 34.1% 0.8% 1.9%
L3 34.7% 7.1%
M 1.2% 0.4%
M1 (WE/AF) 0.6%
M7 (EA) 0.6% 0.4%
N 0.6% 0.4%
N1a (WE/AF) 0.4%
N1b (WE) 0.6%
T 9.9% 2.6%
U 0.6% 14.8% 3.9%
U2, U3, U4, U5 (WE) 13.7% 3.9%
U6a3c (WE/AF) 0.6%
U6a7a (WE/AF) 0.8%
U7a (WE) 0.4%
V 1.2% 3.0%
W 2.7% 1.3%
X 0.6% 1.1%
X2b, X2c, X2i (WE) 1.1%
X2a (NA) 0.6%
Y 0.6%
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reported by the authors and in other studies [48–50].
The composition of the African American, U.S. Caucasian and
U.S. Hispanic populations, and the extent of the diversity withinFig. 1. Biogeographic ancestry proportions in each of the three U.S. population grou
biogeographic ancestry categories (African, East Asian, West Eurasian and Native Americeach of the ancestry groups that contribute to them, are reﬂected in
pairwise comparisons performed for (a) each population sample
and (b) all samples ascribed to each of the four biogeographic
ancestry categories. Fig. 2 displays histograms of pairwise
comparisons for both the full mtGenome and the CR only, for
each of the three populations and three of the four ancestry groups,
plotted by the proportion of comparisons performed to normalize
for the differing sample sizes. The average number of pairwise
differences for each of these sets of comparisons are reported in
Table S6. When the entire mtGenome was considered, the U.S.
Caucasian population sample (Fig. 2b) and the haplotypes of West
Eurasian ancestry (Fig. 2e) had asymmetrical bimodal pairwise
distributions, with the ﬁrst, smaller peak representing the
comparisons between recently diverged lineages in the dataset,
and the second, larger peak representing the comparisons between
more distantly related haplotypes. When these same analyses
were performed with the comparison restricted to the CR (Fig. 2h
and k), the distributions were unimodal and Poisson-like (though
still signiﬁcantly different from a Poisson distribution; p < 0.0001
for both). For the U.S. Hispanic dataset, Fig. 2c displays an
asymmetrical bimodal distribution similar to the U.S. Caucasians,
but with a substantial tail to the right that represents comparisons
to and between the African ancestry haplotypes present in the
population sample. The Native American ancestry comparisons
(Fig. 2f and l) are sharply bimodal and more symmetrical, reﬂecting
the origins of Native Americans and the genetic distance between
the haplotypes in this sample set (primarily, haplogroups A and B
from macrohaplogroup N, and haplogroups C and D from
macrohaplogroup M). The comparisons between these haplotypes
based on the CR alone (Fig. 2l) are the only CR pairwise distribution
that closely mirrors the shape of the distribution based on the full
mtGenome. In contrast to the other sample sets, comparisons of
both the African American population sample and the African
ancestry lineages for the complete mtGenome resulted in
multimodal distributions (Fig. 2a and d) and high average pairwise
numbers of differences (Table S6). In comparison to the U.S.
Caucasian and U.S. Hispanic populations, fewer of the African
American haplotypes are highly similar to one another across the
entire mtGenome, and a much greater number are genetically very
distant. Consistent with results from previous studies of African
American population samples [7,46,48–50], the distributions for
these two comparisons underscore the extensive mtDNA diversity
that exists within the African ancestry component of U.S.
populations.
3.3. Indels and heteroplasmy
Length heteroplasmy (LHP) in the CR has been well-character-
ized in a previous study [51] with a much larger sample size than
we report here, and the observed incidence of LHP across thep samples. Haplotypes for each population were assigned to one of four broad
an) on the basis of EMMA [35] estimated haplogroups using Phylotree build 16 [24].
Table 4
Biogeographic ancestry proportions for each U.S. population from this study and previous CR-based studies. The maternal biogeographic ancestry proportions inferred for
each of the three U.S. populations based on full mtGenome data (this study) and CR data (previous studies). When the proportion of haplotypes assigned to the predominant
biogeographic ancestry for each population group (highlighted rows in the table) were compared, only the frequency of Native American haplotypes in the U.S. Hispanic
population sample in our study versus the Allard et al. [42] data differed signiﬁcantly (p = 0.007).
African American This study (n = 170) Diegoli et al. [45] (n = 248) Allard et al. [41] (n = 1148)
African 90.0% 93.1% 91.6%
East Asian 2.4% 1.1% a
West Eurasian 4.7% 4.3% 5.1%
Native American 2.9% 0.7% a
U.S. Caucasian This study (n = 263) Gonc¸alves et al. [43] (n = 1387) Lao et al. [40] (n = 245)
African 0.8% 0.9% b
East Asian 1.9% a b
West Eurasian 94.7% 96.9% 96.7%
Native American 2.7% a b
U.S. Hispanic This study (n = 155) Saunier et al. [44] (n = 128) Allard et al. [42] (n = 686)
African 12.3% 14.8% 11.8%
East Asian 1.9% 1.6% –
West Eurasian 25.8% 22.7% 17.8%
Native American 60.0% 60.9% 70.8%y
a Cannot be adequately separated based on the data presented in the papers.
b Not reported.
y Signiﬁcantly different from the proportion reported in this study.
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reports (see Table S7). However, a few observations from our data
are worth noting. Overall, we observed LHP in hypervariable region
1 (HV1) in 17.5% of individuals. Consistent with earlier examina-
tions [51–53], LHP in HV1 was observed in every sample in which a
transition at position 16,189 resulted in a homopolymer of nine or
more cytosine residues, and no LHP was observed when seven or
fewer cytosine residues were present. Among the 13 samples in
which some combination of transitions and insertions in HV1
resulted in a homopolymer consisting of exactly eight cytosines,
eight samples had detectible LHP. In the remaining ﬁve samples,
LHP was either not present or was too minor to distinguish from
sequence background/noise. The incidence of HV1 LHP across all
588 samples in this study is signiﬁcantly higher (p = 0.001) than
the 5.0% recently described for a set of 101 western European
individuals [54]. When our data were considered by population,
though, the observed frequency of HV1 LHP varied signiﬁcantly
(p < 0.00001), with a high of 25.2% in the U.S. Hispanic population,
and a low of 9.1% in the U.S. Caucasian population (Table S7). This
latter value is relatively consistent with the data reported by
Ramos et al. [54]; and the differences we observed by population
are largely explained by (a) the nucleotide state at position 16189
(C or T), and (b) the presence or absence of a homopolymer with at
least eight cytosine residues, when these factors are considered by
major haplogroup (see Fig. S4).
LHP in the 523-524 AC repeat region was clearly apparent
(readily observed above sequence background and/or noise upon
initial inspection of the raw data) in 5.3% of the samples in our
dataset. The majority (65%) of instances occurred in samples with
at least six dinucleotide repeats, and all 13 haplotypes with seven
or more AC repeats had clear LHP. This result is consistent with a
previous report on LHP in the AC repeat region, which found
‘‘pronounced’’ AC repeat LHP in 4.3% of samples, and generally in
individuals with six or more dinucleotide repeats [51]. In addition
to the LHP observed in this and the three other expected regions (in
HV1 around position 16193, in HV2 around position 309, and in
HV3 around position 573), a single sample exhibited one further
LHP in the CR, at position 463. This haplotype has T to C transitions
at positions 454, 455 and 460, resulting in a 10 bp cytosine
homopolymer. Overall, across the 588 haplotypes, 374 individuals
(63.6%) exhibited CR LHP, and 87 individuals (14.8%) possessed
LHP in more than one portion of the CR.LHP associated with indels in the coding region was observed in
eleven instances across our three datasets (1.9% of samples), at ﬁve
of the 18 coding region positions at which indels were found
(Table 5). In four individuals, a T to C transition at position 961
resulted in a 10 bp polycytosine tract, and all four of these
haplotypes exhibited LHP at position 965. Similarly, a T to C
transition at position 8277 resulted in a 7 bp polycytosine stretch
in three individuals; and in two of these, cytosine insertions (two
or three) and LHP were observed. In the third individual, no
additional cytosines were present, and no LHP could be detected.
LHP was also observed in one sample at position 8287, due to a T to
C transition at 8286 and cytosine insertions that resulted in a 12 bp
cytosine homopolymer. At position 5899, no LHP was detected
when only a single cytosine was inserted, but LHP was observed in
the three samples with six or more C insertions. And ﬁnally, one
sample had LHP of the 8281-8289 9 bp insertion. In this individual
at least two length variants were detected, and the majority
molecule was two 9 bp insertions.
In addition to the LHP observed at coding region positions with
indels relative to the rCRS, 88.8% of samples had detectible LHP
around position 12425. Positions 12418-12425 are an 8 bp
polyadenine tract, and a mixture of molecules in this region has
been previously described (in a report on mtDNA heteroplasmy
from MPS data [55], and in multiple cancer studies as reviewed in
Lee et al. [56]). In our Sanger data, LHP in this region generally
appeared as a mixture of two molecules consisting of seven or
eight adenine residues (see Fig. S5 for an example). In all cases the
majority molecule matched the rCRS (eight adenines; [32,33]), and
the LHP was generally minor enough that it did not impact
sequence coverage (i.e. in most cases, sequences did not need to be
trimmed). Among most of the 66 individuals in which LHP at
12425 was not identiﬁed or could not be conﬁdently called, nearly
all sequences in the region had noise (i.e. background) to the extent
that the very low level LHP typically observed at 12,425 would be
obscured or difﬁcult to detect. However, for two of the samples, a
transition at position 12425 appears to have prevented LHP.
The frequency of point heteroplasmy (PHP) in the 588
haplotypes was also examined (ﬁndings are summarized in Tables
6 and 7). Across the entire mtGenome, a total of 166 PHPs, in 140
individuals (23.8%) were identiﬁed. Twenty-ﬁve samples (4.3%)
exhibited more than one PHP (24 samples had two PHPs, and one
had three PHPs); and of the individuals with PHP, 17.9% had
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Fig. 2. Haplotype pairwise comparisons. Pairwise comparisons of the haplotypes were performed for each of the three populations and three of the four biogeographic
ancestry groups (African, West Eurasian and Native American). Comparisons for the biogeographic ancestry groups utilized all haplotypes assigned to the ancestry group,
regardless of population. The y-axis indicates the proportion of comparisons performed (to normalize for differing sample sizes), and the x-axis represents the number of
differences. Histograms on the left side of the ﬁgure (panels a through f) represent comparisons performed using the complete mtGenome; whereas for the comparisons on
the right side of the ﬁgure (g through l), the data compared were restricted to the CR. For all analyses, length insertions at positions 309, 573 and 16193 were ignored.
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varied signiﬁcantly between the three populations (p = 0.029).
However, when pairwise comparisons of the populations were
performed, only the comparison between the African American
and U.S. Hispanic populations was signiﬁcant after Bonferroni
correction for multiple tests (p = 0.007992), and the differences
between populations were not signiﬁcant when the CR and coding
region PHPs were considered separately. In a large study of more
than 5000 individuals, Irwin et al. [51] found signiﬁcant variationin the incidence of CR PHP between multiple populations, and
postulated the differences might be due to the differing mtDNA
lineages comprising each of the populations. As Table 3 and Fig. 1
demonstrate, there is certainly extreme variation in the composi-
tion of each of the three U.S. populations described here. Consistent
with a recent study of heteroplasmy in complete mtGenomes [54],
though, no signiﬁcant differences in the frequency of PHP by
haplogroup across the entire mtGenome were observed in our
data, even when statistical analysis was restricted to the eleven
Table 5
Coding region indels. Across all 588 haplotypes, indels were detected at 18 different
positions in the coding region. At three of these 18 positions (960, 5899 and 8289),
both insertions and deletions were observed. LHP was detected at ﬁve of the 18
positions, in eleven total instances. While observation of an indel in multiple
individuals does not necessarily imply multiple occurrences of insertion or deletion
at the position (as some indels are primarily or exclusively haplogroup-associated),
the number of observations does provides some indication of how frequently each
indel might be observed in a population sample.
Indels relative to the
rCRS [32,33]a
Number of
individuals
Instances of
associated LHP
595.1A 1
960 del 1
960.XC 5
965.XC 4 4
2156.1A 3
2232.1A 3
2395 del 13
2887-2888 del 1
3307.1A 1
4317 del 1
5752 del 1
5899 del 1
5752 del 1
5899 del 1
5899.XC 12 3
8278.XC 2 2
8287.XC 1 1
8281-8289 9 bp del 39
8289.X 9 bp ins 7 1
12241 del 1
15944 del 32
a Excludes 3107 del.
Table 7
Point heteroplasmy statistics by region. PHP statistics were calculated for the CR
and the coding region. The number, percentage and ratio of transitions (separated
by type) and transversions are listed for each region of the molecule.
CR Coding region
# of PHP 64 102
# (%) of individuals with PHP 58 (9.9%) 93 (15.8%)
# of positions at which PHP was observed 44 102
# of PHP observed in >1 individual 10a 0
% of individuals with >1 PHP in the region 0.85% 1.53%
# (%) of PHPs that represented transitions 62 (96.9%) 101 (99.0%)
# (%) of PHPs that were pyrimidine–pyrimidine 38 (59.4%) 41 (40.2%)
# (%) of PHPs that were purine–purine 24 (37.5%) 60 (58.8%)
Ratio of pyrimidine to purine PHPs 1.6:1 0.7:1
# (%) of PHPs that represented transversions 2 (3.1%) 1 (1.0%)
Ratio of transition to transversion PHPs 31:1 101:1
a Both 228K and 228R were observed; the total number of positions at which PHP
was observed in >1 individual is 11.
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incidence of PHP by haplogroup). Similarly, no signiﬁcant
differences by haplogroup were observed when PHPs in the CR
and the coding region were considered separately. In the case of
the present study and the results reported by Ramos et al. [54], it
may be that the numbers of samples with PHP on a per-haplogroup
basis are simply too small to detect any non-random differences.
A complete list of the mtGenome positions at which PHP was
detected is given in Table S9. The 64 PHPs observed in the CR were
found in 58 of the 588 individuals (9.9%), at 44 different positions.
For a majority of these positions (75%), PHP was observed in just
one individual. Eight positions (18%) were heteroplasmic in two
individuals (one of these positions, 228, was observed as both 228R
and 228K); and three positions – 189, 152 and 16093 – were
heteroplasmic in four, ﬁve and six individuals, respectively. Several
previous examinations of PHP in the CR have indicated that both
16093 and 152 may be hotspots for heteroplasmy [51,54,57–59].
However, to our knowledge a high observed incidence of PHP at
position 189 has only been reported in muscle tissue samples
associated with increased age [60,61], and in association withTable 6
Point heteroplasmy statistics across all 588 samples and by population. PHP statistics we
of 140 individuals (23.8%) had at least one PHP; and among those individuals with PHP, 2
were seen within one individual 4.3% of the time. The highest number of PHPs observ
All haplotypes 
n (individuals) 588 
# of PHP 166 
# (%) of individuals with PHP 140 (23.8%) 
# (%) of individuals with >1 PHP 25 (4.3%) 
% of individuals with PHP that have >1 PHP 17.9% 
# (%) of individuals with 2 PHP 24 (4.1%) 
# (%) of individuals with 3 PHP 1 (0.2%) 
# (%) of individuals with CR PHP 64 (9.9%) 
# (%) of individuals with coding region PHP 102 (15.8%) increased BMI and insulin resistance [62] (this excludes the data
reported by He et al. [63], which has been shown to be problematic
[64]), though position 189 is recognized as one of the faster
mutating sites in the mtGenome [65–69]. In our data, PHP at 189
occurred on varied haplotypic backgrounds (haplogroups L3b1a4,
U5a1d1, J1c3 and H1ag1), and in two of the three populations.
Visually estimated percentages of the minor molecule across the
four samples with 189 PHP ranged from 5% to 15%. In all four cases
the variant nucleotide was most clearly apparent in the reverse
sequences covering the position, but was conﬁrmed by at least one
(though typically more than one) forward sequence. In three of the
four cases of PHP at 189, the majority molecule matched the rCRS.
No age or health-related information was available for the
anonymized blood serum specimens used for the current study.
A total of 102 PHPs were observed in the coding region. Nine
individuals exhibited more than one coding region PHP, and thus
the total number of individuals with coding region PHP was 93
(15.8%). However, each PHP was unique in the dataset (observed in
only a single individual). The absence of coding region PHPs
detected in more than one individual is consistent with the recent
analysis by Ramos et al. [54], which found 21 unique coding region
PHPs among 101 individuals. Among the 24 coding region PHPs
reported by Li et al. [55], one was shared by more than one
individual; however this PHP (3492M) is unlikely to be authentic in
either individual, given (1) the very low incidence of transversion-
type PHPs reported by Ramos et al. [54] and observed in this study
(see below), (2) the very low frequency of substitution at position
3492 (observed just once, and as a transition, among the more than
2000 mtGenomes analyzed by Soares et al. [69]), (3) the
identiﬁcation (by the authors themselves) of position 3492 as a
sequencing error hot spot, and (4) the coverage dip observed in thisre calculated for all 588 haplotypes and for each of the three U.S. populations. A total
5 (17.9%) had more than one PHP. Thus, across the entire mtGenome, multiple PHPs
ed within a single individual was three.
African American U.S. Caucasian U.S. Hispanic
170 263 155
65 68 33
51 (30.0%) 62 (23.6%) 27 (17.4%)
13 (7.6%) 6 (2.3%) 6 (3.9%)
25.5% 9.7% 22.2%
12 (7.1%) 6 (2.3%) 6 (3.9%)
1 (0.6%) 0 (0.0%) 0 (0.0%)
28 (13.5%) 24 (8.8%) 12 (7.7%)
37 (19.4%) 44 (15.6%) 21 (12.3%)
38% 
7% 
9% 
46% 
Non-coding rRNAs tRNAs Protein-coding genes
Fig. 3. Point heteroplasmies by mtDNA region type. PHPs across all samples were
categorized into four regions: non-coding, rRNAs, tRNAs, and protein-coding genes.
All PHPs in non-coding regions were found in the CR (i.e., no PHPs were observed in
the small intergenic non-coding regions).
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Just, unpublished data; and W. Parson, unpublished data) using
Illumina platforms (Illumina, Inc., San Diego, CA). In a slight
departure from the absence of authentic shared PHPs in the
datasets reported by Ramos et al. [54], Li et al. [55] and in this
study, the haplotypes recently published by King et al. [7] included
three shared PHPs (at positions 1438, 2083, and 8994) among the
58 total coding region PHPs detected (using an 18% threshold) in
283 individuals.
When 203 coding region PHPs (from the 1103 total mtGe-
nomes published by Ramos et al. [54], Li et al. [55] (minus the
3492M PHPs), King et al. [7] and reported in this study) were
considered in combination, only ﬁve additional PHPs were
observed in more than one individual (see Table S10). All ﬁve
of these positions had low relative substitution rates (1–3) among
the 2196 complete mtGenome sequences previously analyzed in a
phylogenetic framework by Soares et al. [69]. In fact, of the 102
coding region PHPs in our data, only two occurred at positions
among the 15 fastest evolving sites in the coding region (and only
four among the 50 fastest sites), while nearly half (44%) occurred
at positions invariant among the >2000 published mtGenomes
included the Soares et al. analysis [69] (see Table S9). In
combination, these studies suggest that the distribution of
heteroplasmy (which should more closely reﬂect mutation rates
than does complete substitution) in the coding region is not
consistent with the gamma-distributed relative substitution rates
reported for the region [69]. This ﬁnding is in contrast to the
general correlation (with a few exceptions) between hetero-
plasmic hotspots and mutation/substitution hotspots in the CR
[51]. The seeming difference between the observed relative
heteroplasmy and substitution rates on a position-by-position
basis in the coding region has several possible explanations,
including selection (at multiple potential levels, e.g. individual,
population, etc.), nucleotide state stability/mutability (that may
be sequence context dependent), and genetic drift. These factors,
alone and in combination, have been previously suggested to
explain the difference between phylogenetic and pedigree
substitution rates in the CR [71–73], departures from the
correlation between observed relative substitution and hetero-
plasmy rates by position in the CR [51,57,58] and patterns of
substitution ([68,69,74,75], among others) and heteroplasmy
[54,76] in the coding region.
In a substantial departure from the above-mentioned studies
regarding heteroplasmy across the mtGenome, a very recent
examination of mtDNA sequences from 1085 individuals using
high coverage depth MPS data and an 1% heteroplasmy detection
threshold found 4342 total PHPs at 2531 mtDNA positions (of
13,659 positions examined), of which only 69.42% were observed
in just a single individual [77]. Relying on the same relative
substitution rates published by Soares et al. [69] referenced above,
Ye et al. [77] reported a positive correlation between relative
substitution rates and heteroplasmy rates (R2 = 0.3702). However,
coding region heteroplasmies were not separated from CR
heteroplasmies for that analysis, and an association between
substitution and heteroplasmy hotspots has been previously
described for the CR [51]. When we applied the same analysis
to all 166 PHPs detected in our study (64 and 102 PHPs in the CR
and coding region, respectively), a similar positive correlation was
observed (R2 = 0.3003, r = 0.5480; see Fig. S6a) despite the clear
lack of correlation between relative substitution rates and
heteroplasmy rates among the coding region PHPs in this study.
When the same regression analysis was performed using only the
3547 coding region PHPs reported by Ye et al. [77], a much weaker
positive correlation between relative substitution rates and
heteroplasmy rates was observed (R2 = 0.1076, r = 0.3280; see
Fig. S6b).Additionally, further examination of the PHPs reported by Ye
et al. [77] indicated that some may be due to mixtures between
distinct individuals/samples, rather than true intraindividual
mtDNA variation [78]. For example, among the 71 PHPs reported
for sample HG00740, nearly all of the positions are diagnostic for
two distinct mtDNA haplogroups (L1b1a1a and B2b3a; according
to Build 16 of PhyloTree [24]). Similar issues were observed among
the PHPs described in another recent report on human mtGenome
heteroplasmy [79]. In that paper, nearly all of the 20 PHPs given for
sample NA12248 (for example) can be ascribed to one of two
haplogroups (U5b2a2b or H1e), and few PHPs that would be
expected from a mixture of two samples representing those
haplogroups are absent. These ﬁndings cast some doubt on the
veracity of the incidence and pattern of heteroplasmy reported in
the Ye et al. [77] and Sosa et al. [79] studies, and thus the
conclusions those authors have drawn from the data.
Among the PHPs observed in the CR in our study, all but two
(97%) were transition-type (purine to purine, or pyrimidine to
pyrimidine) PHPs; and of these, approximately two-thirds were
pyrimidine transitions while one-third were purine transitions
(Table 7 and Fig. S9). The 1.6:1 pyrimidine to purine ratio for PHPs
in the CR is consistent both with earlier analyses of CR
heteroplasmy [51,80] and with the approximately 1.3:1 pyrimi-
dine to purine ratio in the nucleotide composition for the region.
Only one of the 102 PHPs in the coding region was a transversion-
type change, indicating an even more extreme bias toward
transition-type heteroplasmies than has been previously reported
[54,76]. And in contrast to the CR, more of the coding region PHPs
were purine (59%) versus pyrimidine (41%) transitions, despite a
pyrimidine to purine ratio (in terms of average overall nucleotide
composition for the coding region) that is nearly identical to the
CR. The same phenomenon has been observed in previous studies
of both substitution and heteroplasmy in the coding region [54,81].
Fig. 3 displays the proportion of PHPs observed by mtGenome
region in our data; and Fig. 4 details both the proportion of
positions within each coding region gene at which PHP was
observed, and the portion of that variation that would lead to
synonymous and nonsynonymous changes to the amino acid if the
observed mutations were ﬁxed. In our data, the highest rate of PHP
was observed in ATP8 (four PHPs observed across 207 total
positions). The lowest rate of PHP was seen in ND3, with
heteroplasmy observed at just one of 346 possible positions,
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Fig. 4. Point heteroplasmy proportions by gene. PHPs across all protein-coding genes plus the two rRNAs and all tRNAs (combined) were plotted by the fraction of potential
positions (size of the gene) at which PHPs were observed. Thus, the height of each bar in the histogram indicates the relative rate of mutation observed for each gene. The
actual number of PHPs observed for each gene are indicated above the bars. The mutations in the 13 protein-coding genes were categorized as to synonymous or
nonsynonymous amino acid changes if the mutations were to become ﬁxed.
R.S. Just et al. / Forensic Science International: Genetics 14 (2015) 141–155152followed closely by 12S rRNA. Consistent with previous reports on
coding region substitutions [74,81], the highest rate of nonsynon-
ymous variation in our heteroplasmy data was observed in ATP6,
where six of seven PHPs would result in amino acid changes if the
mutations were to become ﬁxed. This 1:0.17 nonsynonymous to
synonymous ratio exceeds the gene with the next highest ratio
(CYTB, 1:0.6) more than 3-fold. However, ATP8, with the highest
overall rate of PHP in this study, and previously reported to have a
high rate of nonsynonymous substitution [81], had one of the
lowest nonsynonymous to synonymous heteroplasmy ratios at
1:3. With regard to codon position, 87% of the 76 PHPs in protein-
coding genes were observed in ﬁrst or third positions, whereas
only 10 were observed in the second codon position (see Table S9).
However, all ﬁrst codon position PHPs we detected were
nonsynonymous changes. Approximately twice as many PHPs
occurred in third versus ﬁrst codon positions, and the ﬁrst to
second to third position ratio for PHPs was 2.2:1:4.5.
Overall, the nonsynonymous to synonymous change ratio for
the 76 PHPs detected in protein-coding genes in our study was
1:1.4, a value that is in close agreement with a recent report on
coding region heteroplasmy [54]. Our ratio is both closer to a
neutral model of sequence evolution and signiﬁcantly different
from some previous examinations of patterns of coding region
substitution in protein coding genes (1:2.32 from Elson et al. [74],
p = 0.035; and 1:2.5 from Kivisild et al. [75], p = 0.013), but is not
signiﬁcantly different from the overall ratio determined from an
evaluation of >5000 published mtGenomes by Pereira et al.
(1:1.97, [81]). However, the ratio from our data was signiﬁcantly
different from the nonsynonymous to synonymous ratio those
authors reported for the substitutions with frequencies at 0.1% or
greater in the dataset (1:2.69, p = 0.006).
In addition to calculations of overall nonsynonymous to
synonymous change ratios, examinations of protein-coding gene
substitutions in previous studies have also found (1) a higher
proportion of nonsynonymous variation and (2) higher pathoge-
nicity scores for nonsynonymous substitutions in younger versusolder branches in the human mtDNA phylogeny and other species
([69,74,75,82,83], among multiple others), both of which provide
further evidence that selection is acting to remove deleterious
mutations from the mtGenome over time. When we compared the
average pathogenicity scores (based on MutPred values [84]
reported by Pereira et al. in their Tables S1 and S3 [83]) for (a) all
possible nonsynonymous substitutions across the mtGenome, (b)
the 60 nonsynonymous PHPs detected in our haplotypes and
reported in three recent studies [7,54,55], and (c) the nonsynon-
ymous substitutions evaluated by Pereira et al. [83] for mtDNA
haplogroup L, M and N trees, the results again indicated that
heteroplasmic changes appear closer to a neutral model of
sequence evolution than do complete substitutions (Fig. S7).
While the difference between the average pathogenicity scores for
heteroplasmies versus all possible substitutions was statistically
signiﬁcant (p = 0.01), the average pathogenicity score for the PHPs
was also signiﬁcantly higher (p = 0.0001) than the average for the
haplogroup L, M and N substitutions with rho values of zero (i.e.,
the mutations observed at the tips of the trees) reported by Pereira
et al. In other words, the heteroplasmic variants in our study have
greater potential for deleterious effect than the most recently
acquired complete substitutions in the haplogroup L, M and N
lineages analyzed by the authors. Given the relative evolutionary
timescales for heteroplasmy versus the ﬁxation of new mutations,
these comparisons between heteroplasmic changes and complete
substitutions in protein-coding genes across both close and distant
human mtDNA lineages thus also appear to provide some further
support for the role of purifying selection in the evolution of the
mtDNA coding region.
4. Conclusions
The 588 complete mtGenome haplotypes that we have reported
here were developed according to current best-practice guidelines
in forensics for the generation and review of mtDNA population
reference data [25,26]. The use of a robust PCR and sequencing
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transfer, adherence to phylogenetic alignment rules [25,26,34]
with reference to the current mtDNA phylogeny [24], repeated
reviews of the raw data, and the inclusion of multiple quality
control measures ensure that these haplotypes meet the highest
data quality standards and are appropriate for forensic use. In
terms of data review, though two laboratories highly accustomed
to examining mtDNA sequence data were involved in this
databasing effort (AFDIL and EMPOP), a small number of haplotype
discrepancies (most regarding missed or misidentiﬁed hetero-
plasmies by one laboratory or the other) were encountered when
the raw data reviews were compared. In addition, two alignments
that did not adhere to the mtDNA phylogeny and were overlooked
by both laboratories were later found upon screening all >2000
indels in the 588 haplotypes. While typically very easily resolved
by re-review of the raw data, these discrepancies and misalign-
ments (all fully corrected in the ﬁnal haplotypes reported here)
once again highlight the importance of incorporating multiple
levels of quality control in the review of mtDNA population
reference data generated for forensic purposes.
The biogeographic ancestry proportions inferred from the full
mtGenome haplotypes are consistent with previously-published
mtDNA CR datasets for the same three U.S. populations, thus
demonstrating that the population samples reported here are as
representative as the reference population data on which current
haplotype frequency estimates rely. The single exception was the
Native American ancestry component of the U.S. Hispanic
population sample, which differed signiﬁcantly between this
and one previous study [42]. This is likely explained by geographic
sampling differences between the earlier study and the U.S.-wide
population sample we report here.
On average, full mtGenome sequencing increased the propor-
tion of unique haplotypes in each population sample by 19.3% over
what would have been achieved with CR sequencing, and by 35.2%
over HV1/HV2 sequencing. Though these resolution improvements
and the overall paucity of shared mtGenome haplotypes in each
population sample (in both this and another recent study [7])
clearly reveal the discriminatory power of complete mtGenome
typing among randomly-sampled individuals, the development of
LRs using the currently-recommended [25] Clopper–Pearson
method for 95% conﬁdence interval calculations [38] will largely
negate this advantage (in terms of describing the statistical weight
of a match for a novel haplotype) until full mtGenome databases
are substantially larger. Because of this, and the anticipated
movement from CR-only sequencing to typing greater portions of
the mtGenome in forensic practice, the question of how best to
capture and convey this additional discriminatory information
arises. For the speciﬁc scenarios presented here, there would seem
to be some beneﬁt in statistical approaches that take into account
both database size and database composition.
As the haplotypes reported here are based on high quality
Sanger sequence data with minimal noise, these 588 proﬁles
permit the most extensive insight to date into the heteroplasmy
observed across a large set of randomly-sampled, population based
complete mtDNAs developed to forensic standards. The incidence
of PHP across the entire mtGenome that we detected – 23.8% of
individuals – is strikingly similar to the PHP frequency described in
two previous analyses [54,55]. This PHP rate is substantially lower
than the incidence of heteroplasmy reported in recent MPS studies
using bioinformatics methods (and in one case, a detection
threshold close to 1%) [77,79]; yet those higher heteroplasmy
rates are questionable due to errors detected in at least some of the
data. A far greater proportion of individuals exhibited LHP in our
study than has been previously reported [54], in largest part due to
(1) the LHP we detected in the 12418-12425 adenine homopoly-
mer, and (2) the differences between the populations examined.When PHP and LHP are considered in combination, nearly all
individuals (96.4%) in this study were heteroplasmic. Though our
data – even when considered in combination with previous studies
– provide only a preliminary look at coding region heteroplasmy
(versus the extent of information now available on mtDNA CR
heteroplasmy), comparisons between coding region heteroplasmy
and substitution patterns seem to provide additional support for
selection as a mechanism of human mtGenome evolution.
The complete mtGenome databases representing the African
American, U.S. Caucasian and U.S. Hispanic populations that we
have developed will be available for query using forensic tools and
parameters in an upcoming version of EMPOP (EMPOP3, with
expected release in late 2014 [36]). In addition, the haplotypes are
currently available in GenBank and in the electronic supplemen-
tary material included with this paper. These extensively vetted
and thoroughly examined Sanger-based population reference data
provide not only a solid foundation for the generation of haplotype
frequency estimates, but can also serve as a benchmark for the
evaluation of future mtGenome data developed for forensic
purposes. This includes comparative examination of the features
(e.g. variable positions, indels, and heteroplasmy) of not only
datasets developed as additional population reference data, but
also single mtGenome haplotypes – especially those generated
using MPS technologies and protocols new to forensics – from
casework specimens.
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